Abstract: Provided is a press machine for driving a slide by a motor, including a control device for controlling driving of the motor, in which the press machine has a press capacity which can be variably controlled by using field control for the motor.

Abstract: An all-solid-state battery includes: a positive electrode active material layer that contains a positive electrode active material, and a first sulfide solid electrolyte material that contacts the positive electrode active material and that substantially does not have a cross-linking chalcogen; a negative electrode active material layer containing a negative electrode active material; and a solid electrolyte layer that is provided between the positive electrode active material layer and the negative electrode active material layer, and that contains a second sulfide solid electrolyte material that substantially has a cross-linking chalcogen.

Abstract: A motor drive control device including a power supply converter that is connected to an alternating-current power supply, a voltage detector that detects a direct-current voltage of the power supply converter, an inverter that is connected to a motor, and an energy storage device that is connected to a direct-current bus that connects the power supply converter and the inverter.

Abstract: In an industrial machine using a flywheel, in order to prevent increase in size of a driving motor, etc. and very freely control velocity of a load, an output shaft of a reduction gear set is connected to a load driving shaft, an input-shaft-sided gear of the reduction gear set is driven by a first motor, a differential mechanism is connected to the flywheel, the differential mechanism is configured such that the output shaft of the reduction gear set is connected to a carrier, rotational force inputted from the sun gear is transmitted to the flywheel and stored as energy while the stored energy is discharged to the sun gear and the carrier. Further, the sun gear of the differential mechanism is driven by a second motor, energy is stored by accelerating the flywheel using the second motor according to the rotational angle position of the load driving shaft, and then the load driving shaft is driven while compensating insufficient torque of the first motor by discharging the stored energy.

Abstract: An elevator in which the sheave diameter is reduced and the attendant lowering of the rope life and strength is suppressed to secure safety and reliability. To this end, a rope is used in which a plurality of element wires constituting the wire rope are each covered with resin material and the whole wire rope is covered with resin material, thereby reducing the wear due to slippage between the element wires and the wear due to contact with the sheave, which wear occurs when the rope is entrained around the sheave. When the elevator sheave diameter is reduced, a worried lowering of the rope life can be suppressed or the rope life can be improved. Thus, it is possible to achieve reduction of size and weight of equipment including motors and hoists, installation space saving for elevators, improved safety and reliability of the system by virtue of the increased rope life.

Abstract: The present invention relates to a therapeutic agent for neuropathic pain containing, as an active ingredient, a compound represented by general formula (I) or a pharmacologically acceptable acid addition salt thereof: (wherein R1, R2, R3, R4, R5, R6, R7, R8, A, and B have the same definitions as those described in the specification), and an animal model produced by administering (+)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octohydro-trans-quinolino[2,3-g]isoquinoline. The present invention makes it possible to perform drug treatment for neuropathic pain. The therapeutic effect of a compound against neuropathic pain can also be evaluated.

Abstract: Disclosed is an agent for improving learning and/or memory, which is useful for therapy of dementia accompanying disorder of memory due to a cerebrovascular disease, neurodegenerative disease such as Alzheimer's disease, endocrine disease, nutritional or metabolic disorder, infectious disease, drug addiction or the like. The agent for improving learning and/or memory according to the present invention comprises as an effective ingredient an isoquinoline derivative having a specific structure, such as (4aR, 12aR)-2-methyl-4a-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12a-octahydro-quinoline[2,3-g]isoquinoline or a pharmaceutically acceptable salt thereof.

Abstract: A quinoline derivative represented by the following formula (1): 1

Abstract: Disclosed is an agent for improving learning and/or memory, which is useful for therapy of dementia accompanying disorder of memory due to a cerebrovascular disease, neurodegenerative disease such as Alzheimer's disease, endocrine disease, nutritional or metabolic disorder, infectious disease, drug addiction or the like. The agent for improving learning and/or memory according to the present invention comprises as an effective ingredient an isoquinoline derivative having a specific structure, such as (4aR, 12aR)-2-methyl-4a-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12a-octahydro-quinoline[2,3-g]isoquinoline or a pharmaceutically acceptable salt thereof.

Abstract: A compound represented by the following formula (12) useful as an intermediate for production of drug or agricultural chemical: 1

Abstract: A drug for curing or preventing mood disorder or anxiety disorder that has fewer and milder side effects comprising, as an effective component, an isoquinoline derivative or a physiologically acceptable acid addition salt thereof, the representative example of the isoquinoline derivative being (4aS, 12aS)-2-methyl-4a-(3-hydroxyphenyl)-1,2,3,4,4a,5,12,12a-octahydroquinolino [2,3-g]isoquinoline; a method for curing or preventing mood disorder or anxiety disorder using the same; and a use of the isoquinoline derivative or the physiologically acceptable acid addition salt thereof for the manufacture of a medicament for curing or preventing mood disorder and anxiety disorder.

Abstract: A method for treating drug dependence comprising administering, as the active ingredient, an opioid &kgr; receptor agonist of a compound represented by the following formula, is disclosed wherein A and the R terms are herein defined.

Abstract: An elevator in which the sheave diameter is reduced and the attendant lowering of the rope life and strength is suppressed to secure safety and reliability. To this end, a rope is used in which a plurality of element wires constituting the wire rope are each covered with resin material and the whole wire rope is covered with resin material, thereby reducing the wear due to slippage between the element wires and the wear due to contact with the sheave, which wear occurs when the rope is entrained around the sheave. When the elevator sheave diameter is reduced, a worried lowering of the rope life can be suppressed or the rope life can be improved. Thus, it is possible to achieve reduction of size and weight of equipment including motors and hoists, installation space saving for elevators, improved safety and reliability of the system by virtue of the increased rope life.

Abstract: A compound represented by the following formula (12) useful as an intermediate for production of drug or agricultural chemical: (wherein R21 to R25 are each independently a hydrogen atom, a hydroxyl group, a halogen atom, an alkyl group of 1 to 4 carbon atoms, an alkoxy group of 1 to 4 carbon atoms, a perfluoroalkyl group of 1 to 4 carbon atoms, a cyano group, a nitro group, an amino group, a carboxyl group, a thiol group, an alkylthio group of 1 to 4 carbon atoms or a carbamoyl group) can be produced by reacting a compound represented by the formula (13): (wherein R21 to R25 have the same definitions as given above) with 1,1-cyclopropanedicarboxylic acid. The compound of the formula (12) is useful as a raw material for production of a pyrrolidinone compound useful as an active ingredient of drug.

Abstract: Disclosed herein is a building equipment managing method using a history database for recording the conditions of building equipment, a display device installed in public spaces of a building, and an input device installed in the public spaces of the building for inputting a request for the indication of necessary information, the method comprising the steps of: recording a change in a condition of the building equipment in the history database; and in response to receiving a request for indicating a content which is recorded in the history database from the input device, indicating on the display device the content which is recorded in the history database.

Abstract: This invention provides an antipruritic comprising an ipoate &kgr; receptor agonist as an effective component, a new morphian quaternary ammonium salt derivative and a new morphian-N-oxide derivative which are useful in treating pruritus complicated with some diseases.

Abstract: This invention provides an antipuritic comprising an opiate &kgr; receptor agonist as an effective component, a new morphian quaternary ammonium salt derivative and a new morphian-N-oxide derivative which are useful in treating puritus complicated with some diseases.

Abstract: An elevator system in which an elevator-car and a counter weight are suspended on a pulley system in a hoistway. The elevator system includes a receiving unit for receiving an electric power from a feeding unit provided in the hoistway, an inverter for converting the received electric power into ac power, a motor connected to an ac side of the inverter for driving the counter weight in up and down directions, a sensor for detecting a position of the receiving unit, and a control unit for controlling an inverter on the basis of the position detected by the position sensor. The counter weight carries the receiving means, the inverter, and the motor.

Abstract: An antitussive agent containing an octahydroisoquinoline derivative represented by the following compound or pharmacologically acceptable acid addition salt thereof: The compounds of the present invention have the significant antitussive action, and can thus be expected as medicines which can be used for all diseases accompanied with coughs, for example, various respiratory diseases such as cold, acute bronchitis, chronic bronchitis, bronchiectasis, pneumonia, pulmonary tuberculosis, silicosis and silicotuberculosis, lung cancer, upper respiratory inflammation (pharyngitis, laryngitis, nasal catarrhalis), asthmatic bronchitis, bronchial asthma, infantile asthma, (chronic) pulmonary emphysema, pneumoconiosis, pulmonary fibrosis, silicosis, pulmonary suppuration, pleurisy, tonsillitis, tussive urticaria, pertussis, etc. and coughs caused in bronchography or bronchoscopy, etc.

Abstract: A morphinan derivative or its pharmacologically allowed acid addition salt represented with compound I, an analgesic and diuretic having its derivative or its salt as the active ingredient, and its production process are described. The compound of the present invention possesses strong analgesic activity and diuretic action as a highly selective &kgr;-opioid agonist, allowing it to be used as a useful analgesic and diuretic.